1. Home
  2. UG vs GRCE Comparison

UG vs GRCE Comparison

Compare UG & GRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UG
  • GRCE
  • Stock Information
  • Founded
  • UG 1942
  • GRCE 2002
  • Country
  • UG United States
  • GRCE United States
  • Employees
  • UG N/A
  • GRCE N/A
  • Industry
  • UG Package Goods/Cosmetics
  • GRCE
  • Sector
  • UG Consumer Discretionary
  • GRCE
  • Exchange
  • UG Nasdaq
  • GRCE NYSE
  • Market Cap
  • UG 36.9M
  • GRCE 40.0M
  • IPO Year
  • UG N/A
  • GRCE N/A
  • Fundamental
  • Price
  • UG $8.30
  • GRCE $2.77
  • Analyst Decision
  • UG
  • GRCE Strong Buy
  • Analyst Count
  • UG 0
  • GRCE 1
  • Target Price
  • UG N/A
  • GRCE $12.00
  • AVG Volume (30 Days)
  • UG 6.0K
  • GRCE 29.0K
  • Earning Date
  • UG 05-08-2025
  • GRCE 06-10-2025
  • Dividend Yield
  • UG 8.43%
  • GRCE N/A
  • EPS Growth
  • UG 4.93
  • GRCE N/A
  • EPS
  • UG 0.63
  • GRCE N/A
  • Revenue
  • UG $11,408,154.00
  • GRCE N/A
  • Revenue This Year
  • UG N/A
  • GRCE N/A
  • Revenue Next Year
  • UG N/A
  • GRCE N/A
  • P/E Ratio
  • UG $13.21
  • GRCE N/A
  • Revenue Growth
  • UG N/A
  • GRCE N/A
  • 52 Week Low
  • UG $7.73
  • GRCE $1.75
  • 52 Week High
  • UG $16.25
  • GRCE $4.97
  • Technical
  • Relative Strength Index (RSI)
  • UG 48.61
  • GRCE N/A
  • Support Level
  • UG $8.00
  • GRCE N/A
  • Resistance Level
  • UG $8.74
  • GRCE N/A
  • Average True Range (ATR)
  • UG 0.29
  • GRCE 0.00
  • MACD
  • UG 0.03
  • GRCE 0.00
  • Stochastic Oscillator
  • UG 37.04
  • GRCE 0.00

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

About GRCE GRACE THERAPEUTICS INC

Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.

Share on Social Networks: